Viñuela-Berni et al. observed an increased number of MPs with CD3, CD14, CD19, CD41, and CD63E antigens in plasma of RA patients with high disease activity (DAS 28 > 5.1) [52]. This evidence concerns the gene CD19 and rheumatoid arthritis.